548 related articles for article (PubMed ID: 35309935)
1. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
2. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.
Huang S; Dong C; Zhang J; Fu S; Lv Y; Wu J
Front Mol Biosci; 2022; 9():943384. PubMed ID: 36052169
[No Abstract] [Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
Front Genet; 2021; 12():796592. PubMed ID: 35126464
[No Abstract] [Full Text] [Related]
6. Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer.
Jiao Z; Feng X; Cui Y; Wang L; Gan J; Zhao Y; Meng Q
BMC Cancer; 2022 Aug; 22(1):871. PubMed ID: 35945523
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
8. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W
Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
11. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
12.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
13. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
14. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
Liu Y; Xie S; Zhu K; Guan X; Guo L; Lu R
Heliyon; 2021 Jun; 7(6):e07257. PubMed ID: 34189308
[TBL] [Abstract][Full Text] [Related]
15. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
16.
Wu G; Chen M; Ren H; Sha X; He M; Ren K; Qi J; Lin F
Front Cell Dev Biol; 2022; 10():930933. PubMed ID: 35874816
[No Abstract] [Full Text] [Related]
17. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
18. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma.
Deng M; Tong R; Zhang Z; Wang T; Liang C; Zhou X; Hou G
Cancer Cell Int; 2021 Oct; 21(1):535. PubMed ID: 34645436
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
